UK unveils £520m for life sciences as part of Autumn Statement 2023
The UK’s Autumn 2023 Statement takes a special interest in revitalising parts of the life sciences scene.
23 November 2023
23 November 2023
The UK’s Autumn 2023 Statement takes a special interest in revitalising parts of the life sciences scene.
CartiHeal's Agili-C solution is indicated to treat roughly 700,000 patients who receive cartilage repair in the US every year.
The system is designed to fit into any room that holds a PET/CT scanner from the Biograph Vision brand.
The reimbursement will allow physicians to use the diagnostic tool to accurately assess patients with cognitive decline.
The new feature allows clinicians to remotely start a scan on a compatible GE HealthCare MR device from a different hospital.
As part of the deal, Cencora will have access to the future technologies of Sapphiros.
Following multiple FDA clearances Brainomix grows its reach in the US with the launch of AI platform Brainomix 360.
Baird Medical’s CEO foresees a US market size potential of $1.6bn for the device, which can be used to remove thyroid nodules.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation, which has improved efficiencies and enhanced patient outcomes. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns.
Give your business an edge with our leading industry insights.